Page last updated: 2024-12-07

chalcone epoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chalcone epoxides are a class of organic compounds that are known for their diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. They are typically synthesized through the epoxidation of chalcones, which are naturally occurring compounds found in various plants. The synthesis of chalcone epoxides often involves the use of oxidizing agents such as m-chloroperbenzoic acid (mCPBA) or hydrogen peroxide. The biological activity of chalcone epoxides is attributed to their ability to interact with various cellular targets, such as enzymes, receptors, and DNA. For example, some chalcone epoxides have been shown to inhibit the growth of cancer cells by interfering with their cell cycle progression. The study of chalcone epoxides is important due to their potential as lead compounds for the development of new drugs. Researchers are actively investigating the structure-activity relationships of these compounds to identify specific modifications that can enhance their therapeutic efficacy and reduce their toxicity. The unique properties of chalcone epoxides make them promising candidates for the treatment of various diseases, including cancer, inflammation, and infections.'

chalcone epoxide: activator of epoxide hydrolase; RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92219
CHEMBL ID1733373
SCHEMBL ID657100
MeSH IDM0092267

Synonyms (50)

Synonym
1,3-diphenyl-2,3-epoxy-1-propanone
chalcone trans-.alpha.,.beta.-epoxide
nsc 402160
chalcone oxide
ccris 2214
trans-phenyl(3-phenyloxiranyl)methanone
propiophenone, 2,3-epoxy-3-phenyl-, trans-
trans-chalcone oxide
chalcone epoxide
nsc10919
nsc-10919
5411-12-1
7570-86-7
nsc402160
phenyl-(3-phenyloxiran-2-yl)methanone
AKOS001028857
phenyl-(3-phenyl-oxiran-2-yl)-methanone
nsc 10919
einecs 226-487-1
methanone, phenyl(3-phenyloxiranyl)-
ai3-50389
phenyl (3-phenyloxiranyl) ketone
FT-0606709
F3097-0430
2-benzoyl-3-phenyloxirane
trans-benzalacetophenone oxide
trans-1,3-diphenyl-2,3-epoxypropan-1-one
phenyl(3-phenyloxiran-2-yl)methanone
STL360884
us8815951, epoxide hydrolase inhibitor 1
bdbm129323
SCHEMBL657100
AKOS016368884
phenyl(3-phenyl-2-oxiranyl)methanone #
chalcone-.alpha.,.beta.-epoxide
CHEMBL1733373
D4378
1,3-diphenyl-2-propen-1-one oxide
mfcd00022336
chalcone alpha,beta-epoxide
Z56758643
phenyl(3-phenyl-2-oxiranyl)methanone
phenyl (3-phenyloxiran-2-yl)methanone
CS-0269728
EN300-16732
DTXSID40968993
3-phenyl-2-benzoyl-oxirane
D90281
chalcone alpha , beta -epoxide
2-(benyzlidene)acetophenone epoxide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (45.00)18.7374
1990's3 (15.00)18.2507
2000's5 (25.00)29.6817
2010's3 (15.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.83 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index33.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]